Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Natural Killer (NK) Cell Therapeutics market report explains the definition, types, applications, major countries, and major players of the Natural Killer (NK) Cell Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Chipscreen Biosciences (China)
Sorrento Therapeutics Inc (USA)
Innate Pharma SA (France)
Altor BioScience Corporation (USA)
NantKwest Inc (USA)
NKT Therapeutics (USA)
Affimed NV (Netherlands)
Bristol-Myers Squibb (USA)
Takeda Pharmaceutical (Japan)
By Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By End-User:
Cancer
Cardiovascular Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Natural Killer (NK) Cell Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Natural Killer (NK) Cell Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Natural Killer (NK) Cell Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Natural Killer (NK) Cell Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Natural Killer (NK) Cell Therapeutics Market- Recent Developments
-
6.1 Natural Killer (NK) Cell Therapeutics Market News and Developments
-
6.2 Natural Killer (NK) Cell Therapeutics Market Deals Landscape
7 Natural Killer (NK) Cell Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Natural Killer (NK) Cell Therapeutics Key Raw Materials
-
7.2 Natural Killer (NK) Cell Therapeutics Price Trend of Key Raw Materials
-
7.3 Natural Killer (NK) Cell Therapeutics Key Suppliers of Raw Materials
-
7.4 Natural Killer (NK) Cell Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Natural Killer (NK) Cell Therapeutics Cost Structure Analysis
-
7.5.1 Natural Killer (NK) Cell Therapeutics Raw Materials Analysis
-
7.5.2 Natural Killer (NK) Cell Therapeutics Labor Cost Analysis
-
7.5.3 Natural Killer (NK) Cell Therapeutics Manufacturing Expenses Analysis
8 Global Natural Killer (NK) Cell Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Natural Killer (NK) Cell Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Natural Killer (NK) Cell Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Natural Killer (NK) Cell Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Natural Killer (NK) Cell Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.2 UK Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.5 France Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.3 India Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)
11 Global Natural Killer (NK) Cell Therapeutics Competitive Analysis
-
11.1 Chipscreen Biosciences (China)
-
11.1.1 Chipscreen Biosciences (China) Company Details
-
11.1.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.1.4 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sorrento Therapeutics Inc (USA)
-
11.2.1 Sorrento Therapeutics Inc (USA) Company Details
-
11.2.2 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.2.4 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Innate Pharma SA (France)
-
11.3.1 Innate Pharma SA (France) Company Details
-
11.3.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.3.4 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Altor BioScience Corporation (USA)
-
11.4.1 Altor BioScience Corporation (USA) Company Details
-
11.4.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.4.4 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 NantKwest Inc (USA)
-
11.5.1 NantKwest Inc (USA) Company Details
-
11.5.2 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.5.4 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 NKT Therapeutics (USA)
-
11.6.1 NKT Therapeutics (USA) Company Details
-
11.6.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.6.4 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Affimed NV (Netherlands)
-
11.7.1 Affimed NV (Netherlands) Company Details
-
11.7.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.7.4 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bristol-Myers Squibb (USA)
-
11.8.1 Bristol-Myers Squibb (USA) Company Details
-
11.8.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.8.4 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Takeda Pharmaceutical (Japan)
-
11.9.1 Takeda Pharmaceutical (Japan) Company Details
-
11.9.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
11.9.4 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Natural Killer (NK) Cell Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Natural Killer (NK) Cell Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Natural Killer (NK) Cell Therapeutics
-
Figure of Natural Killer (NK) Cell Therapeutics Picture
-
Table Global Natural Killer (NK) Cell Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Natural Killer (NK) Cell Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Table North America Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure United States Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure China Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Chipscreen Biosciences (China) Company Details
-
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Sorrento Therapeutics Inc (USA) Company Details
-
Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Innate Pharma SA (France) Company Details
-
Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Altor BioScience Corporation (USA) Company Details
-
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table NantKwest Inc (USA) Company Details
-
Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table NKT Therapeutics (USA) Company Details
-
Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Affimed NV (Netherlands) Company Details
-
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Bristol-Myers Squibb (USA) Company Details
-
Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Table Takeda Pharmaceutical (Japan) Company Details
-
Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Main Business and Markets Served
-
Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product Portfolio
-
Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
